Rett Syndrome
Rett Syndrome is a rare genetic disorder that primarily affects females, leading to severe cognitive and physical impairments, including loss of purposeful hand skills and speech, and often results in repetitive hand movements.
Rett Syndrome: Leriglitazone Study for Children
We are testing the safety and effects of a new medication, leriglitazone, in children with Rett Syndrome. The study aims to understand its impact on development and caregiver challenges.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a girl between 5 and 12 years old?
- Do you have a diagnosis of Rett syndrome (RTT) with a known mutation in the MECP2 gene?
- Are you currently taking any medications that could interfere with the study, like Carbamazepine, Risperidone, or any medications that prolong the QT interval?
- Do you have any known allergies to the study drug or its ingredients?
- Have you had any significant medical issues like cancer, diabetes, or severe heart problems?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Min-102
Leriglitazone
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Sant Joan De Deu Barcelona
Pediatric Neurologist
Esplugues de Llobregat, Spain
Sponsor: Minoryx Therapeutics S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.